相关实验视频
Updated: Jul 23, 2025

06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
21.5K
术前伊瓦布拉丁对选择性抽出 CABG 期间血液动力学的影响
Sanjula Virmani1, Indira Mallik2, Vishwanath B Mohire3
1Department of Anaesthesiology and Intensive Care, G B Pant Institute of Postgraduate Medical Education and Research, J L Nehru Marg, New Delhi, India.
Annals of cardiac anaesthesia
|July 20, 2023
概括
手术前的伊瓦布拉丁可以有效地降低心率 (HR) 在非抽动冠状动脉绕道 (OPCAB) 手术期间,而不会影响血压. 这种HR的减少减少了对β抑制剂的需求,提高了这一手术群体的患者安全.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊瓦布拉丁可以选择性地抑制心脏起器If通道以降低心率 (HR).
- 它保留了心室收缩性,避免了负面的内热或热效应.
- 这项研究探讨了伊瓦布拉丁在非抽动冠状动脉绕道 (OPCAB) 手术中的潜在益处,通过减少HR.
研究的目的:
- 为了评估在接受选择性OPCAB手术的患者手术前给予伊瓦布拉丁的血液动力学影响.
- 评估伊瓦布拉丁是否可以在OPCAB程序期间安全地管理HR.
主要方法:
- 50名患者 (NYHA I/II类) 被随机分配到对照组 (n=25) 和艾瓦布拉丁组 (n=25).
- 伊瓦布拉丁组在手术前3天每天两次服用5毫克.
- 血液动力学参数 (HR,MAP),热血素T和BNP水平被监测;手术内使用β-阻断剂被记录.
主要成果:
- 与对照组 (65.8-80.2 bpm) 相比,伊瓦布拉丁组维持了显著较低的HR (59.6-72.4 bpm).
- 平均动脉压 (MAP) 在各组之间仍然可比.
- 不同于对照组的5名患者,艾瓦布拉丁组中没有患者需要手术时使用甲醇;然而,艾瓦布拉丁组的手术前心率更高.
结论:
- 术前的伊瓦布拉丁对于OPCAB手术患者来说是安全的,它补充了标准的抗痛治疗.
- 伊瓦布拉丁有效地降低了手术内HR,减少了对β-阻断剂的需求.
- 需要进一步研究伊瓦布拉丁在中度至重度左心室功能障碍患者的术后效益.
相关概念视频
Cardiac Catheterization IV: Nursing Management
64
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
64
Cardiomyopathy VII: Pre and Post Operative Nursing Management
16
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Cardiac Catheterization I: Pre-Procedure Overview
68
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
68
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
773
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
773
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
876
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
876

